| 1 |
CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125966
|
| 2 |
ClinicalTrials.gov (NCT03750786) A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer (AGENT). U.S. National Institutes of Health.
|
| 3 |
Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412.
|
| 4 |
CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1126165
|
| 5 |
CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125976
|
|
|
|
|
|
|